Muscle histology vs MRI in Duchenne muscular dystrophy
Authors:
- V. Arechavala-GomezaV. Arechavala-Gomeza
- S. CirakSCS. Cirak
- A. GloverAGA. Glover
- M. GuglieriMGM. Guglieri
- L. FengLFL. Feng
- K.G. HollingsworthKHK.G. Hollingsworth
- D. HuntDHD. Hunt
- H. JungbluthHJH. Jungbluth
- H.P. RoperHRH.P. Roper
- R.M. QuinlivanRQR.M. Quinlivan
- J.A. GosalakkalJGJ.A. Gosalakkal
- 25 January 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 76 (4) , 346-353
Abstract
Objective: There are currently no effective treatments to halt the muscle breakdown in Duchenne muscular dystrophy (DMD), although genetic-based clinical trials are being piloted. Most of these trials have as an endpoint the restoration of dystrophin in muscle fibers, hence requiring sufficiently well-preserved muscle of recruited patients. The choice of the muscles to be studied and the role of noninvasive methods to assess muscle preservation therefore require further evaluation. Methods: We studied the degree of muscle involvement in the lower leg muscles of 34 patients with DMD >8 years, using muscle MRI. In a subgroup of 15 patients we correlated the muscle MRI findings with the histology of open extensor digitorum brevis (EDB) muscle biopsies. Muscle MRI involvement was assigned using a scale 0–4 (normal–severe). Results: In all patients we documented a gradient of involvement of the lower leg muscles: the posterior compartment (gastrocnemius > soleus) was most severely affected; the anterior compartment (tibialis anterior/posterior, popliteus, extensor digitorum longus) least affected. Muscle MRI showed EDB involvement that correlated with the patient9s age (p = 0.055). We show a correlation between the MRI and EDB histopathologic changes, with MRI 3–4 grades associated with a more severe fibro-adipose tissue replacement. The EDB was sufficiently preserved for bulk and signal intensity in 18/22 wheelchair users aged 10–16.6 years. Conclusion: This study provides a detailed correlation between muscle histology and MRI changes in DMD and demonstrates the value of this imaging technique as a reliable tool for the selection of muscles in patients recruited into clinical trials.Keywords
This publication has 23 references indexed in Scilit:
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept studyThe Lancet Neurology, 2009
- 149th ENMC International Workshop and 1st TREAT-NMD Workshop on: “Planning Phase I/II Clinical trials using Systemically Delivered Antisense Oligonucleotides in Duchenne Muscular Dystrophy”Neuromuscular Disorders, 2008
- Three-Point Technique of Fat Quantification of Muscle Tissue as a Marker of Disease Progression in Duchenne Muscular Dystrophy: Preliminary StudyAmerican Journal of Roentgenology, 2008
- Genetic treatments in muscular dystrophiesCurrent Opinion in Neurology, 2007
- Muscle MRI in inherited neuromuscular disorders: Past, present, and futureJournal of Magnetic Resonance Imaging, 2007
- Muscular Dystrophy Campaign Funded Workshop on Management of Scoliosis in Duchenne Muscular Dystrophy 24 January 2005, London, UKNeuromuscular Disorders, 2006
- A short protocol for muscle MRI in children with muscular dystrophiesEuropean Journal of Paediatric Neurology, 2002
- A short protocol for muscle MRI in children with muscular dystrophiesEuropean Journal of Paediatric Neurology, 2002
- A randomized controlled trial of early surgery in duchenne muscular dystrophyNeuromuscular Disorders, 1992
- Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvementBritish Journal of Radiology, 1990